A mathematical model for inflammation and demyelination in multiple sclerosis
Adrianne L. JenneriD, Georgia R. WeatherleyiD, Federico FrascoliiD
Abstract
Multiple sclerosis (MS) is an incurable, life-long disease caused by the demyelination of neurons in the brain and spine. MS is often characterised by relapses in inflammation and demyelination, that are then followed by periods of remittance. Symptoms can be highly debilitating and there are still many open questions about the origin and progression of the disease. Mathematical modelling is well-placed to capture the dynamics of MS and provide insight into disease aetiology. In this work, we present a minimal model for MS disease onset and progression driven by inflammation and demyelination. The model dynamics are capable of describing a typical evolution of the illness, with changes from a healthy state to a diseased scenario captured by certain ranges of parameter values. Our model also describes the non-uniform oscillatory nature of the disease, born from a Hopf bifurcation due to the strength of the inflammatory response. In particular, using experimental data for Contrast Enhancing Lesions (CELs) obtained from MS patients, we are able to reproduce some of the typical relapsing-remitting behaviours of this disease. We hope that the model presented here can serve as a baseline for more complex approaches and as a tool to predict possible evolutions of the disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 9.15
- Field percentile
- top 4%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiscale Modelling of Multiple Sclerosis Initiation and Progression
Thomas Hillen, Adrianne L. Jenner·bioRxiv·Sep 3, 2026
- Excitable dynamics of flares and relapses in autoimmune diseases
Yael Lebel, Tomer Milo, … Uri S. Alon·iSciencePeer-reviewed·Sep 27, 2023
- Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis
Georgia R. Weatherley, Robyn P. Araujo, … Adrianne L. Jenner·PLoS Computational BiologyPeer-reviewed·Jan 20, 2026
- Microglial states determine lesion dynamics in multiple sclerosis
Aletta M.R. van den Bosch, Jia Hui Khoo, … Inge Huitinga·bioRxiv·Oct 25, 2024
- Patient-derived lymphocytes drive smoldering lesion pathology in a chimeric multiple sclerosis mouse model
Océane Perrot, Mathias Nordbeck, … Violetta Zujovic·bioRxiv·Sep 16, 2025
- High neuron-microglia interaction at the node of Ranvier predicts recovery in an inflammatory model of Multiple Sclerosis
Vasiliki Pantazou, Guillaume Dorcet, … Anne Desmazières·bioRxiv·Apr 16, 2026